Engineered Cpf1 variants with altered PAM specificities

Linyi Gao(Broad Institute), David Cox(Broad Institute), Winston X. Yan(Broad Institute), John C. Manteiga(Massachusetts Institute of Technology), Martin Schneider(Broad Institute), Takashi Yamano(The University of Tokyo), Hiroshi Nishimasu(The University of Tokyo), Osamu Nureki(The University of Tokyo), Nicola Crosetto(Science for Life Laboratory), Feng Zhang(Broad Institute)
Nature Biotechnology
June 5, 2017
10.1038/nbt.3900
Cited by 467Open Access
Full Text

Abstract

Related Papers

Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche, Jonathan S. Gootenberg, Omar O. Abudayyeh et al.|Cell|2015|4.9k
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran, Le Cong, Winston X. Yan et al.|Nature|2015|2.7k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew et al.|Nature|2016|2.7k
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker, Linyi Gao, Bernd Zetsche et al.|Science|2015|2.5k
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang, David Bikard, David Cox et al.|Nature Biotechnology|2013|2.5k